DBVTF — DBV Technologies S.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1613780 ·
France
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -50,600,000 | -50,400,000 | 223,200,000 | 174,900,000 | 62,800,000 |
| Mar 2026 | 0 | — | -47,900,000 | -47,600,000 | 266,400,000 | 229,200,000 | 58,500,000 |
| Dec 2025 | 0 | — | -45,048,000 | -44,829,000 | 233,718,000 | 194,167,000 | 64,948,000 |
| Sep 2025 | 0 | — | -34,277,000 | -33,164,000 | 110,495,000 | 69,837,000 | 57,641,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-168,983,000
Investing CF
$-1,869,000
Financing CF
$248,182,000
CapEx
$-1,296,000
Dividends Paid
—
Buybacks
$-159,000
EPS Diluted TTM
$-0.80
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$-270,300,000
Inventory
—
Receivables
$17,300,000
ST Investments
—
EBIT TTM
$-177,825,000
Pretax Income TTM
$-175,219,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,036,000
EBITDA
$-174,762,000
Free Cash Flow
$-104,847,504
Enterprise Value
$1,093,398,656
Total Cash
$174,900,000
Total Debt
$7,700,000
Shares Out
295,939,376
Trailing EPS
$-0.70
Book Value
$0.54
ROE
-142.7%
ROA
-60.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -147,054,000 | -146,947,000 | 233,718,000 | 64,948,000 | — | -121,181,000 |
| Dec 2024 | 0 | -116,590,000 | -113,918,000 | 65,658,000 | 38,271,000 | — | -104,474,000 |
| Dec 2023 | 0 | -76,433,000 | -72,726,000 | 182,986,000 | 42,799,000 | — | -79,653,000 |
| Dec 2022 | 0 | -96,631,000 | -96,274,000 | 246,518,000 | 52,065,000 | — | -55,666,000 |
TTM Snapshot
Revenues TTM
$7,066,000
NetIncome TTM
$-99,704,000
OpCashFlow TTM
$0
Assets (Latest)
$65,658,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $207.87B | $385.16 | — |
| GILD | GILEAD SCIENCES, INC. | $161.66B | $130.21 | — |
| ARGX | ARGENX SE | $53.42B | $853.82 | — |
| RVMD | Revolution Medicines, Inc. | $39.87B | $187.53 | — |
| BIIB | BIOGEN INC. | $29.99B | $202.95 | — |
News headlines (Yahoo Finance, 1h cache)
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
2026-07-30 21:40 · Yahoo
European Equities Traded in US as ADRs Ease in Tuesday Trading
2026-07-28 15:04 · Yahoo
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
2026-07-27 14:31 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
2026-07-24 15:06 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
2026-07-22 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
2026-07-20 15:13 · Yahoo
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales
2026-07-17 21:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Friday
2026-07-17 14:57 · Yahoo
DBV Technologies Q2 Earnings Call Highlights
2026-07-16 23:03 · Yahoo
DBV Technologies Announces the Filing of its 2026 Half-Year Report ― Conditions for Accessing or Consulting the Report
2026-07-16 20:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.